Bezafibrate is a drug used to treat hyperlipidemia and lower cholesterol levels by increasing lipoprotein lipase activity. It is grouped under the following drug class(es): Lipid-lowering agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bezalip, Lipidil, Cedur and Befizal. Its PubChem CID is 39042.
Bezafibrate
| CAS No | 41859-67-0 |
|---|---|
| Molecular Formula | C19H20ClNO4 |
| Molecular Weight | 361.8 g/mol |
| Synonyms | 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bezafibrate is a drug used to treat hyperlipidemia and lower cholesterol levels by increasing lipoprotein lipase activity. It is grouped under the following drug class(es): Lipid-lowering agents.
The listed CAS number is 41859-67-0.
The listed molecular formula is C19H20ClNO4.
The listed molecular weight is 361.8 g/mol.
2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid.
The source lists Bezalip, Lipidil, Cedur and Befizal.